MedPath
Found 4 clinical trials|View Analysis
Sort by:

SPIRIT 2: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

First Posted Date
2017-07-02
Last Posted Date
2021-06-28
Lead Sponsor
Myovant Sciences GmbH
Target Recruit Count
623
Registration Number
NCT03204331
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Aventura, Aventura, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hialeah, Hialeah, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Idaho Falls, Idaho Falls, Idaho, United States

and more 72 locations

SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

First Posted Date
2017-07-02
Last Posted Date
2021-06-28
Lead Sponsor
Myovant Sciences GmbH
Target Recruit Count
638
Registration Number
NCT03204318
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Miami, Miami, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Seattle, Washington, United States

๐Ÿ‡บ๐Ÿ‡ธ

San Diego, San Diego, California, United States

and more 98 locations

LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

First Posted Date
2017-04-06
Last Posted Date
2022-04-20
Lead Sponsor
Myovant Sciences GmbH
Target Recruit Count
382
Registration Number
NCT03103087
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Dallas, Dallas, Texas, United States

๐Ÿ‡ฟ๐Ÿ‡ฆ

Cape Town, Cape Town, Western Cape, South Africa

๐Ÿ‡จ๐Ÿ‡ฟ

Ostrava, Ostrava, Czechia

and more 112 locations

LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

First Posted Date
2017-02-10
Last Posted Date
2022-04-19
Lead Sponsor
Myovant Sciences GmbH
Target Recruit Count
388
Registration Number
NCT03049735
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clearwater, Clearwater, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Hialeah, Hialeah, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Chattanooga, Chattanooga, Tennessee, United States

and more 91 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath